Monitoring of Non-invasive Ventilation

Oslo University Hospital67 enrolled

Overview

The purpose of this study is to determine whether clinical examination, report from ventilator software, nocturnal Sp02 and daytime arterial blood gas are sufficient as screening tools to reveal clinical relevant problems with patients receiving long term treatment with non invasive ventilation.

Patient with chronic hypoventilation with stable on long term treatment (LTMV) with non-invasive ventilation for at least 3 month taking part of our LTMV program will be included. In addition to clinical examination,report from ventilator software, nocturnal Sp02 and daytime arterial blood gas all patients will be investigated with sleep polygraphy and transcutaneous Co2.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hypoventilation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

* Admitted to our unit for optimal treatment of long term non invasive ventilation * Readmitted for control after 6-8 weeks * Then treated for at least 3 month with long term non invasive ventilation outside of hospital. * Informed written consent Exclusion Criteria: * Under 18 years old * Lack of cooperation * Pregnant * Acute exacerbation last 3 month leading to hospital admission. * Change of treatment last 3 month

Locations (1)

Oslo University Hospital

Oslo, Oslo County, Norway

Outcomes

Primary Outcomes

Frequency of transcutaneous co2 revealing sleep hypoventilation, when nocturnal pulseoximeter is normal

Time frame: single night study

Secondary Outcomes

Frequency of patient-ventilator asynchrony during non invasive ventilation ?

Time frame: Single night study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.